• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reaching adults who smoke cigarettes in rural Appalachia: Rationale, design & analysis plan for a mixed-methods study disseminating pharmacy-delivered cessation treatment.在阿巴拉契亚农村地区接触吸烟的成年人:一项混合方法研究的理论基础、设计和分析计划,该研究旨在传播药房提供的戒烟治疗。
Contemp Clin Trials. 2023 Nov;134:107335. doi: 10.1016/j.cct.2023.107335. Epub 2023 Sep 18.
2
Testing the feasibility of the QuitAid smoking cessation intervention in a randomized factorial design in an independent, rural community pharmacy.在一个独立的农村社区药房,采用随机析因设计测试戒烟辅助戒烟干预措施的可行性。
Pilot Feasibility Stud. 2024 Feb 26;10(1):41. doi: 10.1186/s40814-024-01465-9.
3
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法的不同剂量、疗程和给药方式。
Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308.
4
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
5
6
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.药物和电子烟干预成人戒烟的效果:成分网络荟萃分析。
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
7
E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.电子烟与尼古丁替代疗法在英国戒烟服务中的比较:TEC RCT。
Health Technol Assess. 2019 Aug;23(43):1-82. doi: 10.3310/hta23430.
8
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4.
9
Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trial.比较住院吸烟者出院后策略的有效性:帮助 HAND 4 随机对照试验的研究方案。
Trials. 2020 Apr 16;21(1):336. doi: 10.1186/s13063-020-04257-7.
10
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.不同剂量、持续时间和尼古丁替代疗法给药方式对戒烟的效果。
Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2.

引用本文的文献

1
Closing Tobacco Treatment Gaps for Rural Populations: The Role of Clinic-Based Pharmacists at a Federally Qualified Health Center.缩小农村人口的烟草治疗差距:联邦合格健康中心中临床药师的作用。
Pharmacy (Basel). 2025 Jan 26;13(1):10. doi: 10.3390/pharmacy13010010.
2
The potential feasibility of tobacco-focused medication therapy management in pharmacies affiliated with Federally Qualified Health Centers: Perspectives of pharmacists.药房附属联邦合格健康中心烟草药物治疗管理的潜在可行性:药剂师的观点。
J Am Pharm Assoc (2003). 2024 Nov-Dec;64(6):102210. doi: 10.1016/j.japh.2024.102210. Epub 2024 Aug 23.
3
Tobacco Quitline utilization compared with cigarette smoking prevalence in Virginia across rurality and Appalachian Status, 2011-2019.2011 - 2019年弗吉尼亚州农村地区和阿巴拉契亚地区烟草戒烟热线使用率与吸烟率对比
Prev Med Rep. 2024 Apr 6;42:102716. doi: 10.1016/j.pmedr.2024.102716. eCollection 2024 Jun.

本文引用的文献

1
Testing the feasibility of the QuitAid smoking cessation intervention in a randomized factorial design in an independent, rural community pharmacy.在一个独立的农村社区药房,采用随机析因设计测试戒烟辅助戒烟干预措施的可行性。
Pilot Feasibility Stud. 2024 Feb 26;10(1):41. doi: 10.1186/s40814-024-01465-9.
2
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis.社区药房可及性:全国性地理信息系统横断面分析。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1816-1822.e2. doi: 10.1016/j.japh.2022.07.003. Epub 2022 Jul 15.
3
Evaluating the feasibility of pharmacist-facilitated tobacco cessation interventions in independent community pharmacies in rural Appalachia.评估药剂师在阿巴拉契亚农村独立社区药房中实施烟草戒断干预措施的可行性。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1807-1815. doi: 10.1016/j.japh.2022.06.015. Epub 2022 Jul 3.
4
Tobacco Product Use Among Adults - United States, 2020.2020年美国成年人烟草制品使用情况
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):397-405. doi: 10.15585/mmwr.mm7111a1.
5
Analysis of Demographic Characteristics of Users of a Free Tobacco Cessation Smartphone App: Observational Study.免费戒烟智能手机应用程序用户的人口统计学特征分析:观察性研究
JMIR Public Health Surveill. 2022 Mar 9;8(3):e32499. doi: 10.2196/32499.
6
Validity of urges to smoke measures in predicting smoking relapse during treatment in primary care.在初级保健治疗中预测吸烟复发时,吸烟欲望测量的有效性。
NPJ Prim Care Respir Med. 2021 Dec 9;31(1):48. doi: 10.1038/s41533-021-00259-3.
7
Persistent disparities in smoking among rural Appalachians: evidence from the Mountain Air Project.阿巴拉契亚农村地区吸烟情况长期存在的差异:来自山区空气项目的证据。
BMC Public Health. 2021 Feb 2;21(1):270. doi: 10.1186/s12889-021-10334-6.
8
Tobacco Cessation, Rural Residence, and Lung Cancer.戒烟、农村居住与肺癌
J Environ Health Sci. 2020;6(1):1-4. Epub 2020 Feb 17.
9
Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries.评估 Medicare 受益人与初级保健医生的就诊频率与社区药店就诊频率。
JAMA Netw Open. 2020 Jul 1;3(7):e209132. doi: 10.1001/jamanetworkopen.2020.9132.
10
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS).美国国立卫生研究院患者报告结局测量信息系统(PROMIS)药物依从性量表(PMAS)的开发。
Patient Prefer Adherence. 2020 Jun 9;14:971-983. doi: 10.2147/PPA.S249079. eCollection 2020.

在阿巴拉契亚农村地区接触吸烟的成年人:一项混合方法研究的理论基础、设计和分析计划,该研究旨在传播药房提供的戒烟治疗。

Reaching adults who smoke cigarettes in rural Appalachia: Rationale, design & analysis plan for a mixed-methods study disseminating pharmacy-delivered cessation treatment.

机构信息

Medical University of South Carolina, Charleston, SC, USA.

University of Virginia, Department of Public Health Sciences, Charlottesville, VA, USA.

出版信息

Contemp Clin Trials. 2023 Nov;134:107335. doi: 10.1016/j.cct.2023.107335. Epub 2023 Sep 18.

DOI:10.1016/j.cct.2023.107335
PMID:37730197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10841546/
Abstract

INTRODUCTION

Unlike other U.S. geographical regions, cigarette smoking prevalence remains stagnant in rural Appalachia. One avenue for reaching rural residents with evidence-based smoking cessation treatments could be utilizing community pharmacists. This paper describes the design, rationale, and analysis plan for a mixed-method study that will determine combinations of cessation treatment components that can be integrated within community pharmacies in rural Appalachia. The aim is to quantify the individual and synergistic effects of five highly disseminable and sustainable cessation components in a factorial experiment.

METHODS

This sequential, mixed-method research design, based on the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework, will use a randomized controlled trial with a 2 fully crossed factorial design (32 treatment combinations) to test, alone and in combination, the most effective evidence-based cessation components: (1) QuitAid (yes vs. no) (2) tobacco quit line (yes vs. no) (3) SmokefreeTXT (yes vs. no) (4) combination NRT lozenge + NRT patch (vs. NRT patch alone), and (5) eight weeks of NRT (vs. standard four weeks).

RESULTS

Logistic regression will model abstinence at six-months, including indicators for the five treatment factors and all two-way interactions between the treatment factors. Demographic and smoking history variables will be considered to assess potential effect modification. Poisson regression will model quit attempts and percent of adherence to treatment components as secondary outcomes.

CONCLUSION

This study will provide foundational evidence on how community pharmacies in medically underserved, rural regions can be leveraged to increase utilization of existing evidence-based tobacco cessation resources for treating tobacco dependence.

CLINICAL TRIALS

NCT05660525.

摘要

简介

与美国其他地区不同,农村阿巴拉契亚地区的吸烟率仍然停滞不前。利用社区药剂师为农村居民提供基于证据的戒烟治疗可能是一种途径。本文描述了一项混合方法研究的设计、原理和分析计划,该研究旨在确定可以在农村阿巴拉契亚地区的社区药房中整合的戒烟治疗成分组合。目的是通过因子实验量化五种高度可传播和可持续的戒烟成分的单独和协同作用。

方法

这项基于 RE-AIM(可达性、有效性、采用、实施和维持)框架的顺序混合方法研究设计,将使用一项随机对照试验和 2 个完全交叉因子设计(32 种治疗组合),单独和组合测试最有效的基于证据的戒烟成分:(1)QuitAid(是/否)(2)烟草戒烟热线(是/否)(3)SmokefreeTXT(是/否)(4)联合 NRT 含片+NRT 贴剂(与 NRT 贴剂单独使用相比),以及(5)八周 NRT(与标准四周 NRT 相比)。

结果

逻辑回归将对六个月时的戒烟情况进行建模,包括五个治疗因素的指标和治疗因素之间的所有双向交互作用。将考虑人口统计学和吸烟史变量,以评估潜在的效应修饰。泊松回归将对戒烟尝试和治疗成分的依从性百分比进行建模,作为次要结果。

结论

这项研究将为如何利用医疗服务不足的农村地区的社区药房来增加对现有基于证据的烟草戒断资源的利用提供基础证据,以治疗烟草依赖。

临床试验

NCT05660525。